Terns Pharmaceuticals, Inc. · NASDAQ:TERN
Citadel Advisors LLC's stake in Terns Pharmaceuticals, Inc. fell to 4.10% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Citadel Advisors LLC's stake in Terns Pharmaceuticals, Inc. fell to 4.10%, 3,465,307 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 4.10%
- Shares
- 3,465,307
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Citadel Advisors LLC | 3.90% | 3,267,779 |
| Citadel Advisors Holdings LP | 3.90% | 3,267,779 |
| Citadel GP LLC | 3.90% | 3,267,779 |
| Citadel Securities LLC | 0.20% | 197,528 |
| Citadel Securities Group LP | 0.20% | 197,528 |
| Citadel Securities GP LLC | 0.20% | 197,528 |
| Kenneth Griffin | 4.10% | 3,465,307 |
Source
Related
- Terns Pharmaceuticals, Inc.
- Citadel Advisors LLC
- Terns Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Form 4 · Kuriakose Emil · May 5, 2026
- Form 4 · Gengos Andrew · May 5, 2026